<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="11/04/2006" creator="Yo Shidahara" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9120310">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9120310</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Protein_complex" id="T1" lex="nuclear_factor-kappa_B">Nuclear factor-kappa B</term> potently up-regulates the <term sem="DNA_domain_or_region" id="A1"><term sem="Other" id="T2" lex="promoter_activity">promoter activity</term> of <term sem="Protein_molecule" id="T3" lex="RANTES">RANTES</term></term>, a chemokine that blocks <term sem="Virus" id="A2">HIV</term> infection.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="A1" />
<cause idref="T1" />
<clue>Nuclear factor-kappa B potently <clueType>up-regulates</clueType> the promoter activity of RANTES, a chemokine that blocks HIV infection.</clue>
<comment>TPS A1</comment>
</event>
<event id="E2">
<type class="Initiation_of_viral_infection" />
<theme idref="A2" />
<clue>Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV <clueType>infection</clueType>.</clue>
</event>
<event id="E3">
<type class="Negative_regulation" />
<theme idref="E2" />
<cause idref="T3" />
<clue>Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, <corefCause>a chemokine</corefCause> that <clueType>blocks</clueType> HIV infection.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The complex network of <term sem="Protein_family_or_group" id="T4" lex="cytokine">cytokines</term> that are involved in <cons sem="(AND Other Other)" id="T5" lex="(AND inflammatory_response immunoregulatory_response)"><frag id="F1"><term sem="Other" id="A7">inflammatory</term></frag> and <frag id="F2"><term sem="Other" id="A8">immunoregulatory</term></frag> <frag id="F3"><term sem="Other" id="A9">responses</term></frag></cons> plays a critical role in the pathogenesis of <term sem="Other" id="T6" lex="HIV_infection"><term sem="Virus" id="A3">HIV</term> infection</term>.</sentence>
<event id="E4">
<type class="Initiation_of_viral_infection" />
<theme idref="A3" />
<clue>The complex network of cytokines that are involved in inflammatory and immunoregulatory responses plays a critical role in the pathogenesis of HIV <clueType>infection</clueType>.</clue>
</event>
<event id="E5">
<type />
<cause idref="E4" />
<clue>The complex network of cytokines that are involved in inflammatory and immunoregulatory responses plays a critical role in the <clueType>pathogenesis</clueType> <linkTheme>of</linkTheme> HIV infection.</clue>
<comment>SOO</comment>
</event>
<event id="E6">
<type class="Regulation" />
<theme idref1="A9" idref="A7" />
<cause idref="T4" />
<clue>The complex network of cytokines that are <clueType>involved</clueType> <linkTheme>in</linkTheme> inflammatory and immunoregulatory responses plays a critical role in the pathogenesis of HIV infection.</clue>
</event>
<event id="E32">
<type class="Regulation" />
<theme idref1="A9" idref="A8" />
<cause idref="T4" />
<clue>The complex network of cytokines that are <clueType>involved</clueType> <linkTheme>in</linkTheme> inflammatory and immunoregulatory responses plays a critical role in the pathogenesis of HIV infection.</clue>
</event>
<event id="E7">
<type class="Correlation" />
<theme idref="T4" />
<theme idref="T4" />
<clue>The complex <clueType>network</clueType> <linkTheme>of</linkTheme> cytokines that are involved in inflammatory and immunoregulatory responses plays a critical role in the pathogenesis of HIV infection.</clue>
</event>
<event id="E8">
<type class="Regulation" />
<theme idref="E5" />
<cause idref="E7" />
<clue>The complex network of cytokines that are involved in inflammatory and immunoregulatory responses <clueType>plays</clueType> a critical <clueType>role</clueType> <linkTheme>in</linkTheme> the pathogenesis of HIV infection.</clue>
</event>
<sentence id="S3"><term sem="Protein_molecule" id="T7" lex="RANTES">RANTES</term> (<term sem="Protein_molecule" id="T8" lex="regulated_upon_activation,_normal_T_cell_expressed_and_secreted">regulated upon activation, normal T cell expressed and secreted</term>) is a <term sem="Protein_family_or_group" id="T9" lex="cytokine">cytokine</term> that belongs to the <term sem="Protein_family_or_group" id="T10" lex="beta-chemokine_family">beta-chemokine family</term>; it is chemoattractant for <term sem="Cell_natural" id="T11" lex="CD4+/CD45RO_T_cell">CD4+/CD45RO T cells</term>, it is produced by various cell types including <cons sem="(AND Cell_natural Cell_natural)" id="T12" lex="(AND CD8+_T_cell CD4+_T_cell)"><frag id="F4">CD8+</frag> and <frag id="F5">CD4+</frag> <frag id="F6">T cells</frag></cons> as well as <term sem="Cell_natural" id="T13" lex="monocytes/macrophages">monocytes/macrophages</term>, and has recently been shown to suppress replication of <term sem="Virus" id="A4">macrophage-tropic strains of <term sem="Virus" id="T14" lex="HIV">HIV</term></term> in <term sem="Cell_natural" id="T15" lex="CD4+_T_cell">CD4+ T cells</term>.</sentence>
<event id="E9">
<type class="Biological_process" />
<theme idref="T7" />
<theme idref="T11" />
<clue>RANTES (regulated upon activation, normal T cell expressed and secreted) is a cytokine that belongs to the beta-chemokine family; <corefCause>it</corefCause> is <clueType>chemoattractant</clueType> <linkTheme>for</linkTheme> CD4+/CD45RO T cells, it is produced by various cell types including CD8+ and CD4+ T cells as well as monocytes/macrophages, and has recently been shown to suppress replication of macrophage-tropic strains of HIV in CD4+ T cells.</clue>
<comment>TPS A4</comment>
</event>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T7" />
<clue>RANTES (regulated upon activation, normal T cell expressed and secreted) is a cytokine that belongs to the beta-chemokine family; it is chemoattractant for CD4+/CD45RO T cells, <corefTheme>it</corefTheme> is <clueType>produced</clueType> <clueLoc>by various cell types</clueLoc> including CD8+ and CD4+ T cells as well as monocytes/macrophages, and has recently been shown to suppress replication of macrophage-tropic strains of HIV in CD4+ T cells.</clue>
</event>
<event id="E110">
<type class="Gene_expression" />
<theme idref="T7" />
<clue>RANTES (regulated upon activation, normal T cell expressed and secreted) is a cytokine that belongs to the beta-chemokine family; it is chemoattractant for CD4+/CD45RO T cells, <corefTheme>it</corefTheme> is <clueType>produced</clueType> <clueLoc>by</clueLoc> various cell types including <clueLoc>CD8+</clueLoc> and CD4+ <clueLoc>T cells</clueLoc> as well as monocytes/macrophages, and has recently been shown to suppress replication of macrophage-tropic strains of HIV in CD4+ T cells.</clue>
</event>
<event id="E210">
<type class="Gene_expression" />
<theme idref="T7" />
<clue>RANTES (regulated upon activation, normal T cell expressed and secreted) is a cytokine that belongs to the beta-chemokine family; it is chemoattractant for CD4+/CD45RO T cells, <corefTheme>it</corefTheme> is <clueType>produced</clueType> <clueLoc>by</clueLoc> various cell types including CD8+ and <clueLoc>CD4+ T cells</clueLoc> as well as monocytes/macrophages, and has recently been shown to suppress replication of macrophage-tropic strains of HIV in CD4+ T cells.</clue>
</event>
<event id="E310">
<type class="Gene_expression" />
<theme idref="T7" />
<clue>RANTES (regulated upon activation, normal T cell expressed and secreted) is a cytokine that belongs to the beta-chemokine family; it is chemoattractant for CD4+/CD45RO T cells, <corefTheme>it</corefTheme> is <clueType>produced</clueType> <clueLoc>by</clueLoc> various cell types including CD8+ and CD4+ T cells as well as <clueLoc>monocytes</clueLoc>/macrophages, and has recently been shown to suppress replication of macrophage-tropic strains of HIV in CD4+ T cells.</clue>
</event>
<event id="E410">
<type class="Gene_expression" />
<theme idref="T7" />
<clue>RANTES (regulated upon activation, normal T cell expressed and secreted) is a cytokine that belongs to the beta-chemokine family; it is chemoattractant for CD4+/CD45RO T cells, <corefTheme>it</corefTheme> is <clueType>produced</clueType> <clueLoc>by</clueLoc> various cell types including CD8+ and CD4+ T cells as well as monocytes/<clueLoc>macrophages</clueLoc>, and has recently been shown to suppress replication of macrophage-tropic strains of HIV in CD4+ T cells.</clue>
</event>
<event id="E11">
<type class="Viral_life_cycle" />
<theme idref="A4" />
<clue>RANTES (regulated upon activation, normal T cell expressed and secreted) is a cytokine that belongs to the beta-chemokine family; it is chemoattractant for CD4+/CD45RO T cells, it is produced by various cell types including CD8+ and CD4+ T cells as well as monocytes/macrophages, and has recently been shown to suppress <clueType>replication</clueType> <linkTheme>of</linkTheme> macrophage-tropic strains of HIV in CD4+ T cells.</clue>
</event>
<event id="E12">
<type class="Negative_regulation" />
<theme idref="E11" />
<cause idref="T7" />
<clue>RANTES (regulated upon activation, normal T cell expressed and secreted) is a cytokine that belongs to the beta-chemokine family; it is chemoattractant for CD4+/CD45RO T cells, <corefCause>it</corefCause> is produced by various cell types including CD8+ and CD4+ T cells as well as monocytes/macrophages, and has recently been shown to <clueType>suppress</clueType> replication of macrophage-tropic strains of HIV <clueLoc>in CD4+ T cells.</clueLoc></clue>
</event>
<sentence id="S4">To investigate the <term sem="Other" id="T16" lex="molecular_mechanism">molecular mechanisms</term> of <term sem="Other" id="T17" lex="RANTES_expression"><term sem="Protein_molecule" id="T18" lex="RANTES">RANTES</term> expression</term>, the <term sem="DNA_domain_or_region" id="T19" lex="RANTES_promoter_region"><term sem="Protein_molecule" id="T20" lex="RANTES">RANTES</term> promoter region</term> was analyzed by <term sem="Other" id="T21" lex="transient_expression">transient expression</term> and <term sem="Other" id="T22" lex="gel-mobility_shift_assay">gel-mobility shift assays</term>.</sentence>
<sentence id="S5">We demonstrate that: 1) <term sem="Other" id="T24" lex="promoter_activity"><term sem="Protein_molecule" id="T23" lex="RANTES">RANTES</term> promoter activity</term> is up-regulated by <term sem="Organic_compound_other" id="T25" lex="PMA">PMA</term> plus <term sem="Organic_compound_other" id="T26" lex="ionomycin">ionomycin</term>, coexpression of the <term sem="Protein_molecule" id="T27" lex="p65_subunit">p65 subunit</term> of <term sem="Protein_complex" id="T28" lex="nuclear_factor_(NF)-kappa_B">nuclear factor (NF)-kappa B</term>, the <term sem="Protein_family_or_group" id="T29" lex="proinflammatory_cytokine">proinflammatory cytokines</term> <term sem="Protein_molecule" id="T30" lex="TNF-alpha">TNF-alpha</term> and <term sem="Protein_molecule" id="T31" lex="IL-1_beta">IL-1 beta</term>, and the <term sem="Other" id="T32" lex="CD28_costimulatory_pathway"><term sem="Protein_molecule" id="T33" lex="CD28">CD28</term> costimulatory pathway</term>; 2) the <term sem="DNA_domain_or_region" id="T34" lex="RANTES_promoter_region"><term sem="Protein_molecule" id="T35" lex="RANTES">RANTES</term> promoter region</term> contains four <term sem="DNA_domain_or_region" id="T36" lex="NF-kappa_B_binding_site"><term sem="Protein_complex" id="T37" lex="NF-kappa_B">NF-kappa B</term> <term sem="DNA_domain_or_region" id="T38" lex="binding_site">binding sites</term></term> at <cons sem="(AND DNA_domain_or_region DNA_domain_or_region DNA_domain_or_region DNA_domain_or_region)" id="T39" lex="(AND position_-30 position_-44 position_-213 position_-579)"><frag id="F7">positions</frag> <frag id="F8">-30</frag>, <frag id="F9">-44</frag>, <frag id="F10">-213</frag>, and <frag id="F11">-579</frag></cons> relative to the <term sem="DNA_domain_or_region" id="T40" lex="transcription_start_site">transcription start site</term>; 3) <term sem="DNA_domain_or_region" id="A5">one site</term> (-213) is an <term sem="DNA_domain_or_region" id="T41" lex="NF-AT_(nuclear_factor_of_activated_T_cells)_binding_site"><term sem="Protein_family_or_group" id="T42" lex="NF-AT">NF-AT</term> (<term sem="Protein_family_or_group" id="T43" lex="nuclear_factor_of_activated_T_cells">nuclear factor of activated T cells</term>) binding site</term> that also has weak affinity to <term sem="Protein_complex" id="T44" lex="NF-kappa_B">NF-kappa B</term>, and the most distal site (-579) also serves as a <term sem="DNA_domain_or_region" id="T45" lex="CD28-responsive_element">CD28-responsive element</term>; and 4) mutation on any of those <term sem="DNA_domain_or_region" id="T46" lex="NF-kappa_B_site"><term sem="Protein_complex" id="T47" lex="NF-kappa_B">NF-kappa B</term> sites</term> or coexpression of <term sem="Protein_molecule" id="T48" lex="I_kappa_B_alpha">I kappa B alpha</term> (<term sem="Protein_molecule" id="T49" lex="cytoplasmic_inhibitor_of_NF-kappa_B">cytoplasmic inhibitor of <term sem="Protein_complex" id="T50" lex="NF-kappa_B">NF-kappa B</term></term>) markedly reduced the <term sem="Other" id="T51" lex="promoter_activity">promoter activity</term>.</sentence>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="T24" />
<cause idref="T25" />
<cause idref="T26" />
<clue>We demonstrate that: 1) RANTES promoter activity is <clueType>up-regulated</clueType> <linkCause>by</linkCause> PMA <linkCause>plus</linkCause> ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
<comment>NER T24 mod</comment>
</event>
<event id="E14">
<type class="Gene_expression" />
<theme idref="T27" />
<clue>We demonstrate that: 1) RANTES promoter activity is up-regulated by PMA plus ionomycin, <clueType>coexpression</clueType> <linkCause>of</linkCause> the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
</event>
<event id="E28">
<type class="Gene_expression" />
<theme idref="T30" />
<clue>We demonstrate that: 1) RANTES promoter activity is up-regulated by PMA plus ionomycin, <clueType>coexpression</clueType> <linkCause>of</linkCause> the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
</event>
<event id="E29">
<type class="Gene_expression" />
<theme idref="T31" />
<clue>We demonstrate that: 1) RANTES promoter activity is up-regulated by PMA plus ionomycin, <clueType>coexpression</clueType> <linkCause>of</linkCause> the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="T24" />
<cause idref="E14" />
<clue>We demonstrate that: 1) RANTES promoter activity is <clueType>up-regulated</clueType> <linkCause>by</linkCause> PMA plus ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
</event>
<event id="E30">
<type class="Positive_regulation" />
<theme idref="T24" />
<cause idref="E28" />
<clue>We demonstrate that: 1) RANTES promoter activity is <clueType>up-regulated</clueType> <linkCause>by</linkCause> PMA plus ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
</event>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="T24" />
<cause idref="E29" />
<clue>We demonstrate that: 1) RANTES promoter activity is <clueType>up-regulated</clueType> <linkCause>by</linkCause> PMA plus ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
</event>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="T24" />
<cause idref="T32" />
<clue>We demonstrate that: 1) RANTES promoter activity is <clueType>up-regulated</clueType> <linkCause>by</linkCause> PMA plus ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
</event>
<event id="E17">
<type class="Binding" />
<theme idref="A5" />
<theme idref="T44" />
<clue>We demonstrate that: 1) RANTES promoter activity is up-regulated by PMA plus ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also <clueType>has weak affinity</clueType> <linkTheme>to</linkTheme> NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
</event>
<event id="E18">
<type class="Mutagenesis" />
<theme idref="T46" />
<clue>We demonstrate that: 1) RANTES promoter activity is up-regulated by PMA plus ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) <clueType>mutation</clueType> on any <linkTheme>of</linkTheme> those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
<comment>ARTIFICIAL</comment>
</event>
<event id="E19">
<type class="Negative_regulation" />
<theme idref="T51" />
<cause idref="E18" />
<clue>We demonstrate that: 1) RANTES promoter activity is up-regulated by PMA plus ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly <clueType>reduced</clueType> the promoter activity.</clue>
</event>
<event id="E20">
<type class="Gene_expression" />
<theme idref="T48" />
<clue>We demonstrate that: 1) RANTES promoter activity is up-regulated by PMA plus ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or <clueType>coexpression</clueType> <linkTheme>of</linkTheme> I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly reduced the promoter activity.</clue>
</event>
<event id="E21">
<type class="Negative_regulation" />
<theme idref="T51" />
<cause idref="E20" />
<clue>We demonstrate that: 1) RANTES promoter activity is up-regulated by PMA plus ionomycin, coexpression of the p65 subunit of nuclear factor (NF)-kappa B, the proinflammatory cytokines TNF-alpha and IL-1 beta, and the CD28 costimulatory pathway; 2) the RANTES promoter region contains four NF-kappa B binding sites at positions -30, -44, -213, and -579 relative to the transcription start site; 3) one site (-213) is an NF-AT (nuclear factor of activated T cells) binding site that also has weak affinity to NF-kappa B, and the most distal site (-579) also serves as a CD28-responsive element; and 4) mutation on any of those NF-kappa B sites or coexpression of I kappa B alpha (cytoplasmic inhibitor of NF-kappa B) markedly <clueType>reduced</clueType> the promoter activity.</clue>
</event>
<sentence id="S6">Thus, <term sem="Protein_complex" id="T52" lex="NF-kappa_B">NF-kappa B</term>, a potent transcriptional activator of <term sem="Other" id="T53" lex="HIV_expression"><term sem="Virus" id="T54" lex="HIV">HIV</term> expression</term>, is also involved in the expression of <term sem="Protein_molecule" id="T55" lex="RANTES">RANTES</term>, a <term sem="Protein_family_or_group" id="T56" lex="chemokine">chemokine</term> that blocks infection by <term sem="Virus" id="A6"><term sem="Virus" id="T57" lex="macrophage-tropic_strain">macrophage-tropic strains</term> of <term sem="Virus" id="T58" lex="HIV">HIV</term></term>.</sentence>
<event id="E22">
<type class="Gene_expression" />
<theme idref="T54" />
<clue>Thus, NF-kappa B, a potent transcriptional activator of HIV <clueType>expression</clueType>, is also involved in the expression of RANTES, a chemokine that blocks infection by macrophage-tropic strains of HIV.</clue>
<comment>TPS A6</comment>
</event>
<event uncertainty="probable" id="E23">
<type class="Positive_regulation" />
<theme idref="E22" />
<cause idref="T52" />
<clue>Thus, NF-kappa B, a potent <clueType>transcriptional activator</clueType> <linkTheme>of</linkTheme> HIV expression, is also involved in the expression of RANTES, a chemokine that blocks infection by macrophage-tropic strains of HIV.</clue>
</event>
<event id="E24">
<type class="Gene_expression" />
<theme idref="T55" />
<clue>Thus, NF-kappa B, a potent transcriptional activator of HIV expression, is also involved in the <clueType>expression</clueType> <linkTheme>of</linkTheme> RANTES, a chemokine that blocks infection by macrophage-tropic strains of HIV.</clue>
</event>
<event id="E25">
<type class="Positive_regulation" />
<theme idref="E24" />
<cause idref="T52" />
<clue>Thus, NF-kappa B, a potent transcriptional activator of HIV expression, is also <clueType>involved</clueType> <linkTheme>in</linkTheme> the expression of RANTES, a chemokine that blocks infection by macrophage-tropic strains of HIV.</clue>
</event>
<event id="E26">
<type class="Initiation_of_viral_infection" />
<theme idref="A6" />
<clue>Thus, NF-kappa B, a potent transcriptional activator of HIV expression, is also involved in the expression of RANTES, a chemokine that blocks <clueType>infection</clueType> <linkTheme>by</linkTheme> macrophage-tropic strains of HIV.</clue>
</event>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E26" />
<cause idref="T55" />
<clue>Thus, NF-kappa B, a potent transcriptional activator of HIV expression, is also involved in the expression of RANTES, <corefCause>a chemokine</corefCause> that <clueType>blocks</clueType> infection by macrophage-tropic strains of HIV.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
